APA (7th ed.) Citation

Mielnicka, N., Dutka, M., Kułak, K., Kułak, A., & Tarkowski, R. (2025). A New Direction in Endometrial Cancer Therapy—PD-1 and PD-L1 Immune Checkpoint Inhibitors—Where Will It Take Us? Journal of Clinical Medicine, 14(23), 8366. https://doi.org/10.3390/jcm14238366

Chicago Style (17th ed.) Citation

Mielnicka, Natalia, Martyna Dutka, Krzysztof Kułak, Anna Kułak, and Rafał Tarkowski. "A New Direction in Endometrial Cancer Therapy—PD-1 and PD-L1 Immune Checkpoint Inhibitors—Where Will It Take Us?" Journal of Clinical Medicine 14, no. 23 (2025): 8366. https://doi.org/10.3390/jcm14238366.

MLA (9th ed.) Citation

Mielnicka, Natalia, et al. "A New Direction in Endometrial Cancer Therapy—PD-1 and PD-L1 Immune Checkpoint Inhibitors—Where Will It Take Us?" Journal of Clinical Medicine, vol. 14, no. 23, 2025, p. 8366, https://doi.org/10.3390/jcm14238366.